Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Science. 1993 Nov 5;262(5135):900-2.

Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.

Author information

  • 1Departments of Growth and Development, and Anatomy, University of California at San Francisco 94143-0640.

Abstract

Transforming growth factor-beta (TGF-beta) and activin signal primarily through interaction with type I and type II receptors, which are transmembrane serine-threonine kinases. Tsk 7L is a type I receptor for TGF-beta and requires coexpression of the type II TGF-beta receptor for ligand binding. Tsk 7L also specifically bound activin, when coexpressed with the type IIA activin receptor. Tsk 7L could associate with either type II receptor and the ligand binding specificity of Tsk 7L was conferred by the type II receptor. Tsk 7L can therefore act as type I receptor for both activin and TGF-beta, and possibly other ligands.

PMID:
8235612
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk